CT强化评估用于甲状腺癌转移性淋巴结术前诊断:不同经验水平放射科医生的比较
本研究纳入399例分化型甲状腺癌患者的463枚淋巴结,由3名不同经验放射科医生独立分析CT上淋巴结强化的定性与定量参数。定量参数观察者间一致性优良(ICC 0.83-0.94),定性分析仅为中等(κ=0.61);除LNV外各定量参数诊断转移性淋巴结的AUC为0.81-0.85,NAVCCA与AD最高(均0.85)。除NAVIJV外,定量参数AUC显著高于低经验放射科医生的定性评估,与高经验放射科医生无显著差异。
要点
- 定量CT参数观察者间一致性ICC 0.83-0.94,优于定性分析的κ=0.61。
- NAVCCA与AD的AUC均为0.85,为诊断转移性淋巴结表现最佳的定量参数。
- 除NAVIJV外,定量参数AUC显著高于低经验医生的定性评估,与高经验医生无显著差异。
核心结论
- 动脉期CT淋巴结强化的定量评估观察者间一致性及AUC均高于低经验放射科医生的定性分析,支持建立基于定量CT参数的标准化模型判定淋巴结强强化。
研究设计与样本
- 本研究纳入399例分化型甲状腺癌患者的463枚淋巴结,3名放射科医生独立分析CT上淋巴结强强化,比较定性与定量分析的观察者间一致性和诊断效能。
关键影像表现/征象
- 强强化的定性分析定义为动脉期淋巴结皮质强化程度高于相邻肌肉。
- 定量分析包括动脉期淋巴结平均衰减值(LNA)和静脉期平均衰减值(LNV)。
- 定量分析还包括LNA分别经颈总动脉(NAVCCA)、颈内静脉(NAVIJV)和胸锁乳突肌(NAVSCM)归一化。
- 定量分析还包括衰减差AD(LNA减MAVSCM)和相对廓清率((LNA-LNV)/LNA×100)。
诊断标准与关键数值
- 所有定量CT参数观察者间一致性优良(ICC 0.83-0.94),定性评估为中等(κ=0.61)。
- 除LNV外,所有CT参数对转移性淋巴结诊断表现良好(AUC 0.81-0.85)。
- NAVCCA(AUC 0.85,95%CI 0.8-0.9)与AD(AUC 0.85,95%CI 0.81-0.89)AUC最高。
- 除NAVIJV外,所有定量参数AUC显著高于低经验放射科医生的定性评估,与高经验放射科医生的评估无显著差异。
临床应用与阅片要点
- 作者认为,评估分化型甲状腺癌淋巴结强强化时,定量CT参数可提高观察者间一致性,且不受经验水平影响。
- 作者认为,可能有必要开发基于定量CT参数的标准化诊断模型。
- 术前准确评估甲状腺癌淋巴结转移至关重要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the diagnostic performance and interobserver agreement of quantitative CT parameters indicating strong lymph node (LN) enhancement in differentiated thyroid cancer (DTC), comparing them with qualitative analysis by radiologists of varying experience.
MATERIALS AND METHODS: This study included 463 LNs from 399 patients with DTC. Three radiologists independently analyzed strong LN enhancement on CT. Qualitative analysis of strong enhancement was defined as LN cortex showing greater enhancement than adjacent muscles on the arterial phase. Quantitative analysis included the mean attenuation value (MAV) of LN on arterial phase (LNA) and venous phase (LNV), LNA normalized to the common carotid artery (NAVCCA), internal jugular vein (NAVIJV), and sternocleidomastoid muscle (NAVSCM), attenuation difference [AD; (LNA - MAVSCM)], and relative washout ratio [((LNA - LNV)/LNA) × 100]. The interobserver agreement and diagnostic performance of the quantitative and qualitative analyses were evaluated.
RESULTS: Interobserver agreement was excellent for all quantitative CT parameters (ICC, 0.83-0.94) and substantial for qualitative assessment (κ = 0.61). All CT parameters except for LNV showed good diagnostic performance for metastatic LNs (AUC, 0.81-0.85). NAVCCA (0.85, 95% CI: 0.8-0.9) and AD (0.85, 95% CI: 0.81-0.89) had the highest AUCs. All quantitative parameters except for NAVIJV had significantly higher AUCs than qualitative assessments by inexperienced radiologists, with no significant difference from assessments by an experienced radiologist.
CONCLUSION: Quantitative assessment of LN enhancement on arterial phase CT showed higher interobserver agreement and AUC values than qualitative analysis by inexperienced radiologists, supporting the need for a standardized quantitative CT parameter-based model for determining strong LN enhancement.
CLINICAL RELEVANCE STATEMENT: When assessing strong LN enhancement in DTC, quantitative CT parameters indicating strong enhancement can improve interobserver agreement, regardless of experience level. Therefore, the development of a standardized diagnostic model based on quantitative CT parameters might be necessary.
KEY POINTS: Accurate preoperative assessment of LN metastasis in thyroid cancer is crucial. Quantitative CT parameters indicating strong LN enhancement demonstrated excellent interobserver agreement and good diagnostic performance. Quantitative assessment of contrast enhancement offers a more objective model for the identification of metastatic LNs.
引用
- Roh YH, Chung SR, Yang SJ, et al. Enhancement on CT for preoperative diagnosis of metastatic lymph nodes in thyroid cancer: a comparison across experience levels. Eur Radiol. 2024. PMID: 38980412. doi:10.1007/s00330-024-10919-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。